Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F J Couch

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Cancer Research|June 15, 1996
Mutations of the BRCA2 gene in ovarian carcinomasH Takahashi, H C Chiu, C A Bandera, et al.
Journal of the National Cancer Institute|November 8, 2001
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriersL C Hartmann, T A Sellers, D J Schaid, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 29, 1999
Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer familiesT A Sellers, R A King, J R Cerhan, et al.
Nature Genetics|May 1, 1996
BRCA2 germline mutations in male breast cancer cases and breast cancer familiesF J Couch, L M Farid, M L DeShano, et al.
Cancer Research|August 2, 2001
Genetic analysis of early- versus late-stage ovarian tumorsV Shridhar, J Lee, A Pandita, et al.
Genomics|October 15, 1996
Characterization of EZH1, a human homolog of Drosophila Enhancer of zeste near BRCA1K J Abel, L C Brody, J M Valdes, et al.
Genomics|August 15, 1996
Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13F J Couch, J M Rommens, S L Neuhausen, et al.
British Journal of Cancer|September 10, 2009
Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysisJ M Cunningham, R A Vierkant, T A Sellers, et al.
Journal of Medical Genetics|June 1, 2005
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variantsP K Lovelock, S Healey, W Au, et al.
British Journal of Cancer|August 2, 2012
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2G C Wishart, C D Bajdik, E Dicks, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Cancer Research|June 15, 1996
Mutations of the BRCA2 gene in ovarian carcinomasH Takahashi, H C Chiu, C A Bandera, et al.
Journal of the National Cancer Institute|November 8, 2001
Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriersL C Hartmann, T A Sellers, D J Schaid, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 29, 1999
Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer familiesT A Sellers, R A King, J R Cerhan, et al.
Nature Genetics|May 1, 1996
BRCA2 germline mutations in male breast cancer cases and breast cancer familiesF J Couch, L M Farid, M L DeShano, et al.
Cancer Research|August 2, 2001
Genetic analysis of early- versus late-stage ovarian tumorsV Shridhar, J Lee, A Pandita, et al.
Genomics|October 15, 1996
Characterization of EZH1, a human homolog of Drosophila Enhancer of zeste near BRCA1K J Abel, L C Brody, J M Valdes, et al.
Genomics|August 15, 1996
Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13F J Couch, J M Rommens, S L Neuhausen, et al.
British Journal of Cancer|September 10, 2009
Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysisJ M Cunningham, R A Vierkant, T A Sellers, et al.
Journal of Medical Genetics|June 1, 2005
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variantsP K Lovelock, S Healey, W Au, et al.
British Journal of Cancer|August 2, 2012
PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2G C Wishart, C D Bajdik, E Dicks, et al.
Pageof 7